
An ad campaign by Pancreatic Cancer Action has drawn criticism from other charities for ‘pitting’ different types of cancer against …

Celgene’s cancer drug Abraxane has been approved by European regulators to treat patients with metastatic adenocarcinoma of the pancreas, or …
Biotech company Amgen has abandoned its late-stage trial of a new drug for one of the most hard-to-treat of all …
A new cancer survival study shows that pancreatic cancer continues to have one of the worst mortality rates. The study …
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations

